Sat, Aug 23, 2014, 4:15 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • hippocampus48 hippocampus48 Feb 18, 2013 10:03 AM Flag

    AF is right again!

    From the last 20 or so posts ( from knowledgable postings) it seems that IMUC has used a very favorable 14.5 month OS in their previous comparisons. We should be using a more realistic 17-18 month comparison. This seems very puzzling since at the last presentation we were led to expect a 32 death threshold this 1st Quarter which would mean little or no benefit??????? Even a 2nd QTR 32 threshold would mean that a much larger P3 taking years would need to be initiated fro possible approval. May be this is why the stock is still a $2 stock?

0.913+0.013(+1.44%)Aug 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.